In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Jaguar Health Inc (NASDAQ: JAGX) closed at $0.97 in the last session, down -0.59% from day before closing price of $0.98. In other words, the price has decreased by -$0.59 from its previous closing price. On the day, 0.7 million shares were traded. JAGX stock price reached its highest trading level at $1.0199 during the session, while it also had its lowest trading level at $0.96.
Ratios:
We take a closer look at JAGX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.36 and its Current Ratio is at 1.84. In the meantime, Its Debt-to-Equity ratio is 2.13 whereas as Long-Term Debt/Eq ratio is at 1.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 07, 2021, initiated with a Overweight rating and assigned the stock a target price of $5.
On July 11, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $2.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAGX now has a Market Capitalization of 11436092 and an Enterprise Value of 29874880. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.09 while its Price-to-Book (P/B) ratio in mrq is 0.74. Its current Enterprise Value per Revenue stands at 2.933 whereas that against EBITDA is -1.015.
Stock Price History:
Over the past 52 weeks, JAGX has reached a high of $21.60, while it has fallen to a 52-week low of $0.90. The 50-Day Moving Average of the stock is -10.46%, while the 200-Day Moving Average is calculated to be -75.69%.
Shares Statistics:
According to the various share statistics, JAGX traded on average about 334.86K shares per day over the past 3-months and 687040 shares per day over the past 10 days. A total of 10.42M shares are outstanding, with a floating share count of 8.06M. Insiders hold about 12.74% of the company’s shares, while institutions hold 3.10% stake in the company. Shares short for JAGX as of 1730332800 were 332319 with a Short Ratio of 1.54, compared to 1727654400 on 413029. Therefore, it implies a Short% of Shares Outstanding of 332319 and a Short% of Float of 3.5999999999999996.
Earnings Estimates
The performance of Jaguar Health Inc (JAGX) in the stock market is under the watchful eye of 1 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.72, with high estimates of -$0.72 and low estimates of -$0.72.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is -$2.06, with 1 analysts recommending between -$2.06 and -$2.06.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $3.29M. There is a high estimate of $3.29M for the next quarter, whereas the lowest estimate is $3.29M.
Based on 1 analysts’ estimates, the company’s revenue will be $15.84M in the next fiscal year. The high estimate is $15.84M and the low estimate is $15.84M.
